Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

NCT00035815 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
330
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mayo Clinic

Collaborators